Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder

Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder

10.1001/archgenpsychiatry.2010.179

Saved in:

Bibliographic Details
Main Authors:	Perlis, R.H., Uher, R., Ostacher, M., Goldberg, J.F., Trivedi, M.H., Rush, A.J., Fava, M.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110490
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Diurnal mood variation in outpatients with major depressive disorder
by: Morris, D.W., et al.
Published: (2014)

A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder
by: Cusin, C., et al.
Published: (2014)

Assessing anxious features in depressed outpatients
by: Mcclintock, S.M., et al.
Published: (2014)

Indicators of pretreatment suicidal ideation in adults with major depressive disorder
by: Morris, D.W., et al.
Published: (2014)

The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: A STAR*D report
by: Haley, C.L., et al.
Published: (2014)

A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence
by: Brown, E.S., et al.
Published: (2014)

Visual contrast sensitivity in major depressive disorder
by: Fam, J., et al.
Published: (2014)

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes
by: Davis, L.L., et al.
Published: (2014)

Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: An exploratory analysis of a single-blind randomized trial
by: Davis, L.L., et al.
Published: (2014)

Do atypical features affect outcome in depressed outpatients treated with citalopram?
by: Stewart, J.W., et al.
Published: (2014)

Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients
by: Trivedi, M.H., et al.
Published: (2014)

Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder
by: Maneeton N., et al.
Published: (2017)

The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registry
by: McAllister-Williams, R.H., et al.
Published: (2021)

Depression outcomes of Spanish- and english-speaking hispanic outpatients in STAR*D
by: Lesser, I., et al.
Published: (2014)

Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder
by: Narong Maneeton, et al.
Published: (2018)

Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder
by: Narong Maneeton, et al.
Published: (2018)

Clinical and Socio-Demographic Correlates of Anxious Distress in Asian Outpatients with Major Depressive Disorder
by: Narong Maneeton, et al.
Published: (2018)

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication
by: McClintock, S.M., et al.
Published: (2014)

Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies
by: Uher, R., et al.
Published: (2014)

The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: A post hoc analysis
by: Rakofsky, J.J., et al.
Published: (2014)

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
by: Bhattacharyya, S., et al.
Published: (2021)

Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder
by: Tan, X.W., et al.
Published: (2021)

Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group
by: Han, L.K.M., et al.
Published: (2022)

Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, Asian outpatients with major depressive disorder
by: Manit Srisurapanont, et al.
Published: (2018)

Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, Asian outpatients with major depressive disorder
by: Manit Srisurapanont, et al.
Published: (2018)

Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder
by: Tan, Xiao Wei, et al.
Published: (2020)

Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study
by: Denninger, J.W., et al.
Published: (2014)

Gender-specific structural abnormalities in major depressive disorder revealed by fixel-based analysis
by: Lyon, M., et al.
Published: (2021)

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report
by: Bobo, W.V., et al.
Published: (2014)

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: A proof of concept
by: Kaddurah-Daouk, R., et al.
Published: (2014)

Profound and reproducible patterns of reduced regional gray matter characterize major depressive disorder
by: Hellewell, S.C., et al.
Published: (2021)

Adherence to antidepressant combinations and monotherapy for major depressive disorder: A CO-MED report of measurement-based care
by: Warden, D., et al.
Published: (2014)

Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder
by: Cutler, J.A., et al.
Published: (2014)

The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women
by: Kornstein, S.G., et al.
Published: (2014)

What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression
by: Gaynes, B.N., et al.
Published: (2014)

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
by: Nelson Rodrigues, et al.
Published: (2020)

Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder - Possible Role for Methoxyindole Pathway
by: Zhu, H., et al.
Published: (2014)

Increased Cooperative Behavior Across Remitted Bipolar I Disorder and Major Depression: Insights Utilizing a Behavioral Economic Trust Game
by: Ong, Desmond C, et al.
Published: (2020)

Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report
by: Sung, S.C., et al.
Published: (2014)

What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?
by: Gollan, J.K., et al.
Published: (2014)